Zydus gains final USFDA approval for Amantadine extended-release capsules 68.5 mg and tentative approval for 137 mg Read more
Alkem signs non-exclusive patent license agreement with Takeda to commercialise Vonoprazan in India Read more
Merck administers dose to first patient in Phase III study of Oral Cladribine in Generalised Myasthenia Gravis (gMG) Read more